
Shire
Europe, Dublin, Ireland, Dublin'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Description
Shire biotechnology company that focuses on serving people with rare diseases.
Investor Profile
Shire has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 17% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Belgium, France.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series B (33%)
- Series C (25%)
- Series D (17%)
- Series A (17%)
- Series Unknown (8%)
Country Focus
- United States (75%)
- Belgium (17%)
- France (8%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Life Science
- Biopharma
- Pharmaceutical
- Medical
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Shire frequently co-invest with?
What are some of recent deals done by Shire?
Find More Investors Like Shire
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









